雜志介紹

Multiple Sclerosis And Related Disorders雜志介紹

《Multiple Sclerosis And Related Disorders》是一本以English為主的未開放獲取國際優秀期刊，中文名稱多發性硬化癥及相關疾病，本刊主要出版、報道醫學-CLINICAL NEUROLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.9，最新CiteScore 指數為5.8。

本刊近期中國學者發表的論文主要有：

• Safety of inactivated COVID-19 vaccines in autoimmune encephalitis: A real-world cross-sectional survey

  Author: Liu, Xu; Guo, Kundian; Lu, Lu; Luo, Rong; Liu, Jie; Zhou, Dong; Hong, Zhen

• Significant retinal microvascular impairments in multiple sclerosis assessed through optical coherence tomography angiography

  Author: Wang, Xuejiao; Wang, Xuqian; Chou, Yuyu; Ma, Jin; Zhong, Yong

• Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder

  Author: Yuan, Congcong; Liu, Xueyu; Cai, Shuang; Zhang, Lu; Guo, Ruoyi; Jia, Zhen; Sun, Yafei; Li, Bin

• Differentiation of MOGAD in ADEM-like presentation children based on FLAIR MRI features

  Author: Wei, Shaonong; Xu, Lu; Zhou, Deyang; Wang, Tianlei; Liu, Kezhou; Gao, Feng; Cao, Jiuwen

英文介紹

Multiple Sclerosis And Related Disorders雜志英文介紹

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource.

A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.